Long gamma nail versus sliding hip screw for the treatment of unstable pertrochanteric hip fractures

A prospective randomised controlled trial comparing the long gamma nail with the sliding hip screw for the treatment of unstable pertrochanteric hip fractures

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN79362886

Enrollment

320

Registered

2009-04-07

Start date

2003-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable pertrochanteric fractures of the proximal femur Injury, Occupational Diseases, Poisoning Fracture of femur

Interventions

Patients entered into the trial were randomised to fixation of their proximal femoral fracture by either a sliding hip screw (Omega® II, Stryker, UK) or a long gamma nail (Dyax®, Stryker, UK). Rando

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients (both males and females) over the age of 18 years admitted to the treating hospital with an unstable pertrochanteric hip fracture.

Exclusion criteria

Exclusion criteria: 1. Pathological fractures 2. Previous proximal femoral fractures 3. Decision of the admitting physician

Design outcomes

Primary

Measure	Time frame
Re-operation within the first post-operative year.	—

Secondary

Measure	Time frame
1. Mortality in the first post-operative year 2. Requirement for a blood transfusion within one week of surgery 3. Length of hospital stay 4. Mobility and residency at one year 5. Euroqol EQ-5D at 3, 6 and 12 months post-operation	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026